FRIDAY, Jan. 28, 2022 (HealthDay News) — COVID-19 vaccines activate long-lasting immune system T-cells that target coronavirus variants of concern, including Delta and Omicron, new research shows. The research team at the La Jolla Institute for Immunology in California studied adults who were fully vaccinated with the Pfizer, Moderna, JohnsonContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — In response to claims that a man was denied a heart transplant because he refused to get vaccinated against COVID-19, Brigham and Women’s Hospital in Boston said Wednesday that its transplant policies mirror those used across the United States. In a crowdfunding appealContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — Finding the right medication for rheumatoid arthritis isn’t easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms. The study was mandated by the U.S. Food andContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — COVID-19 is changing medicine in yet another way: A new study finds that patients with COVID-related lung damage now account for nearly one in 10 lung transplants in the United States. The researchers analyzed data on more than 3,000 lung transplants nationwide betweenContinue Reading

WEDNESDAY, Jan. 26, 2022 (HealthDay News) — A one-two punch from science has clearly tagged the mononucleosis virus, Epstein-Barr, as a major cause of multiple sclerosis. The Epstein-Barr virus (EBV) appears to trigger multiple sclerosis (MS) by tricking the immune systems of some into attacking their body’s own nerve cells,Continue Reading

WEDNESDAY, Jan. 26, 2022 (HealthDay News) — Belly fat is usually unwelcome, but new research suggests it may actually be good for something: relief from foot pain. A small pilot study suggests that an injection of a patient’s own fat cells can help ease the often-excruciating heel pain brought onContinue Reading

WEDNESDAY, Jan. 26, 2022 (HealthDay News) — Saline intravenous (IV) fluids are as effective as more costly solutions in treating intensive care patients and keeping them alive, Australian researchers report. “Just about every patient admitted to the intensive care unit (ICU) will receive intravenous fluids for resuscitation or as partContinue Reading